Newsblare

Top 50            Stocks to Buy

Pharma & Healthcare Top 50

From Abbott to Pfizer: List of Top 50 Pharma Companies of India

India’s pharmaceutical industry or top pharma companies of India has experienced remarkable growth and transformation over the years, making it one of the world’s most prominent players in the global pharmaceutical market. With a burgeoning domestic market and an increasing focus on research and development, India has produced a diverse array of pharmaceutical companies that

Read More
Pharma & Healthcare

Moderna Updated Covid Vaccine Shines Against the ‘Eris’ Variant

In an initial study, Moderna found that its updated Covid vaccine was effective against “Eris” and “Fornax” subvariants. In the coming weeks, the updated shot is expected to be available for the fall vaccination season, pending approval from health regulators in the United States, Europe, and elsewhere. Novavax, Pfizer, and BioNTech have developed shots aimed

Read More
Pharma & Healthcare

How Integrated Healthcare Systems are Streamlining Patient Care

In an era where technology influences every aspect of our lives, healthcare is no exception. Integrated healthcare systems are innovative platforms changing the healthcare landscape by streamlining patient care. But what exactly are these systems, and why are they essential? With the help of cutting-edge technology and improved inter-professional communication, integrated healthcare is paving the

Read More
Pharma & Healthcare

How Metaverse Could Revolutionize Mental Healthcare – The WEF Report

A report released by the World Economic Forum -WEF on Monday, June 26, has stated that Metaverse technology could be a solution to the growing need to combat mental healthcare -related issues globally. One of the country’s most critical public health concerns – excessive screen time and social media usage – has been declared a

Read More
Pharma & Healthcare

8 Strategies To Build a Medical Device Manufacturing Business

Starting a medical device company is a great way to move your idea to market. The industry is on track to be worth $500 billion globally. If you have an idea for a new device, take some time to consider if you should build a company around your product. Before starting your medical device manufacturing

Read More
Pharma & Healthcare

Is Now the Time to Sell Your Medical Practice?

Over the years, you’ve invested your time, energy, and resources into building your medical practice. It’s more than just a business – it’s a testament to your commitment to providing high-quality healthcare to your community. But now, you find yourself grappling with a question that many healthcare practitioners eventually face: “Is now the time to

Read More
Pharma & Healthcare

It is expected that Mankind Pharma will open its IPO next week, on April 25, for a total of Rs 4,326 crore

Despite an uncertain macroeconomic environment, condom manufacturer Mankind Pharma is planning to open its IPO on April 25 and close it on April 27. There is an IPO price range of $1,026 – $1,080 per share. The company’s shares are currently commanding a huge grey market premium, or GMP, of $100 per share. Before they

Read More
Pharma & Healthcare

Covid-19 vaccine efficacy can be affected by air pollution: Study

A study suggests that people exposed to high levels of air pollution before the pandemic have lower antibody responses to Covid-19 vaccine. According to researchers from the Barcelona Institute for Global Health (ISGlobal) and the German Trias i Pujol Research Institute (IGTP) in Spain, exposure to fine particulates (PM2.5), nitrogen dioxide (NO2), and blank carbon

Read More
Pharma & Healthcare

Pfizer Acquires Seagen: What Does This Multibillion-Dollar Deal Mean for the Biotech Industry?

A $43 billion deal has been reached between Pfizer and Seagen. The Wall Street Journal reported that Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering cancer drugs. In the deal, Pfizer will pay USD 229 in cash per share, according to the drugmaker. The deal, which includes debt, is

Read More
Pharma & Healthcare

By 2040, India’s chemical demand is expected to reach $1,000 billion

During the next two decades, India will contribute more than a fifth of incremental global chemical consumption, according to a report by McKinsey, as domestic demand is expected to reach USD 1,000 billion by 2040. According to McKinsey’s report titled ‘India: The next chemicals manufacturing hub’, the country’s chemical industry has outperformed global peers when

Read More